•
Dec 31, 2017

ResMed Q2 2018 Earnings Report

Total Revenue
$601M
Previous year: $530M
+13.4%
EPS
$1
Previous year: $0.73
+37.0%
Gross Profit
$350M
Previous year: $309M
+13.2%
Cash and Equivalents
$859M
Previous year: $788M
+9.0%
Free Cash Flow
$117M
Previous year: $191M
-39.1%
Total Assets
$3.56B
Previous year: $3.32B
+7.3%

ResMed

ResMed